Lificiguat

DB19979ExperimentalSmall molecule

Lificiguat is a small molecule drug. The usage of the INN stem '-ciguat' in the name indicates that Lificiguat is a guanylate cyclase activator and stimulator. Lificiguat has a monoisotopic...

Formula / weight: C₁₉H₁₆N₂O₂ · 304.349 g/mol (avg)
Code names: NSC-728165

Resolves to

Compound

UNII515CC1WPTECAS170632-47-0ChEMBLCHEMBL333985ChEBI93060PubChem5712

Structure

InChIKeyOQQVFCKUDYMWGV-UHFFFAOYSA-NSMILESOCC1=CC=C(O1)C1=NN(CC2=CC=CC=C2)C2=CC=CC=C12

Targets

Q15910EZH2Q02108GUCY1A1Q02153GUCY1B1Q16665HIF1A

What you can answer from here — as of September 23, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Lificiguat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account